Eventum Orthopeadics, an Ilkley, UK-based medtech company which has developed a device for knee replacement surgery, raised £2.5M in Series A funding.
The round was led by NPIF – Mercia Equity Finance, which is managed by Mercia and is part of the Northern Powerhouse Investment Fund, Mercia’s EIS funds and private investors, some of whom are orthopaedic surgeons.
The company intends to use the funds to continue to begin production, expand its sales and technical team and apply for FDA approval in the US.
Founded in 2020 by John Naybour and Paul Atherton, Eventum provides Quadsense, a device that measures the forces of a patient’s quadriceps muscles across the range of leg motions before and during surgery, enabling surgeons to position the kneecap in such a way that the patient retains the same muscle balance and regains normal knee function. It has now achieved UK CA approval and the ISO13485 standard for medical devices, and has been used in 20 operations in New Zealand in conjunction with robotic surgery.
FinSMEs
16/03/2023